BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walters KA, Gilchrist RB, Ledger WL, Teede HJ, Handelsman DJ, Campbell RE. New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins. Trends Endocrinol Metab 2018;29:841-52. [PMID: 30195991 DOI: 10.1016/j.tem.2018.08.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Cao LY, Zhang ZQ, Liu PP, Xu DF, Tang L, Fan L, Sun XC, Li JY, Wu QF, Li ZM, Tan J. Aberrant BMP15/HIF-1α/SCF signaling pathway in human granulosa cells is involved in the PCOS related abnormal follicular development. Gynecol Endocrinol 2022;:1-7. [PMID: 36151730 DOI: 10.1080/09513590.2022.2125951] [Reference Citation Analysis]
2 Chauhan N, Peter A, Soni S, Rawal R, Jain U. Biomaterials as regenerative medicine in Poly Cystic Ovarian Syndrome (PCOS) treatment. Biochemical Engineering Journal 2022. [DOI: 10.1016/j.bej.2022.108649] [Reference Citation Analysis]
3 Muccee F, Bijou O, Harakeh S, Adawiyah R, Sayyed RZ, Haghshenas L, Alshehri D, Ansari MJ, Ghazanfar S. In-Silico Investigation of Effects of Single-Nucleotide Polymorphisms in PCOS-Associated CYP11A1 Gene on Mutated Proteins. Genes 2022;13:1231. [DOI: 10.3390/genes13071231] [Reference Citation Analysis]
4 Hu L, Ma L, Xia X, Ying T, Zhou M, Zou S, Yu H, Yin J. Efficacy of bariatric surgery in the treatment of women with obesity and polycystic ovary syndrome. J Clin Endocrinol Metab 2022:dgac294. [PMID: 35554540 DOI: 10.1210/clinem/dgac294] [Reference Citation Analysis]
5 Abruzzese GA, Silva AF, Velazquez ME, Ferrer MJ, Motta AB. Hyperandrogenism and Polycystic ovary syndrome: Effects in pregnancy and offspring development. WIREs Mech Dis 2022;:e1558. [PMID: 35475329 DOI: 10.1002/wsbm.1558] [Reference Citation Analysis]
6 Silva MSB, Campbell RE. Polycystic Ovary Syndrome and the Neuroendocrine Consequences of Androgen Excess. Compr Physiol 2022;12:3347-69. [PMID: 35578968 DOI: 10.1002/cphy.c210025] [Reference Citation Analysis]
7 Yang Z, Cai X, Xu X, Xu Z, Ye S, Wang Y, Hong Y, Shen B, Liao Q, Xie Z, Wang X. Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome. Anal Biochem 2022;:114665. [PMID: 35339450 DOI: 10.1016/j.ab.2022.114665] [Reference Citation Analysis]
8 Garg A, Patel B, Abbara A, Dhillo WS. Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2022. [PMID: 35262967 DOI: 10.1111/cen.14704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Szeliga A, Rudnicka E, Maciejewska-jeske M, Kucharski M, Kostrzak A, Hajbos M, Niwczyk O, Smolarczyk R, Meczekalski B. Neuroendocrine Determinants of Polycystic Ovary Syndrome. IJERPH 2022;19:3089. [DOI: 10.3390/ijerph19053089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kolan Ska-Dams E, Boinska J, Socha MW. Adipokine levels and carbohydrate metabolism in patients diagnosed de novo with polycystic ovary syndrome. Qatar Med J 2021;2021:34. [PMID: 34604014 DOI: 10.5339/qmj.2021.34] [Reference Citation Analysis]
11 Ozgen Saydam B, Yildiz BO. Polycystic Ovary Syndrome and Brain: An Update on Structural and Functional Studies. J Clin Endocrinol Metab 2021;106:e430-41. [PMID: 33205212 DOI: 10.1210/clinem/dgaa843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kiconco S, Teede HJ, Azziz R, Norman RJ, Joham AE. The Need to Reassess the Diagnosis of Polycystic Ovary Syndrome (PCOS): A Review of Diagnostic Recommendations from the International Evidence-Based Guideline for the Assessment and Management of PCOS. Semin Reprod Med 2021;39:71-7. [PMID: 34404096 DOI: 10.1055/s-0041-1735259] [Reference Citation Analysis]
13 Rotgers E, Nicol B, Rodriguez K, Rattan S, Flaws JA, Yao HH. Constitutive expression of Steroidogenic factor-1 (NR5A1) disrupts ovarian functions, fertility, and metabolic homeostasis in female mice. FASEB J 2021;35:e21770. [PMID: 34288113 DOI: 10.1096/fj.202100304R] [Reference Citation Analysis]
14 Tomatis V, Battipaglia C, Genazzani AD. Thyroid, Adrenal, PRL Impairments and Ovarian Function. Endocrines 2021;2:212-25. [DOI: 10.3390/endocrines2030021] [Reference Citation Analysis]
15 Stener-Victorin E, Padmanabhan V, Walters KA, Campbell RE, Benrick A, Giacobini P, Dumesic DA, Abbott DH. Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome. Endocr Rev 2020;41:bnaa010. [PMID: 32310267 DOI: 10.1210/endrev/bnaa010] [Cited by in Crossref: 45] [Cited by in F6Publishing: 72] [Article Influence: 45.0] [Reference Citation Analysis]
16 Sati A, Prescott M, Holland S, Jasoni CL, Desroziers E, Campbell RE. Morphological evidence indicates a role for microglia in shaping the PCOS-like brain. J Neuroendocrinol 2021;33:e12999. [PMID: 34216402 DOI: 10.1111/jne.12999] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Simons PIHG, Valkenburg O, Bons JAP, Stehouwer CDA, Brouwers MCGJ. The relationships of sex hormone-binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome. Endocrinol Diabetes Metab 2021;4:e00267. [PMID: 34277990 DOI: 10.1002/edm2.267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Mohammadi M, Fatemi I, Taghipour Z, Azin M, Kaeidi A, Hakimizadeh E, Taghizadeh R, Hassanipour M. Polycystic Ovary Syndrome Can Lead to Neurocognitive Changes in Female Rats Treated with Letrozole. Arch Neurosci 2021;8. [DOI: 10.5812/ans.112023] [Reference Citation Analysis]
19 Bulsara J, Patel P, Soni A, Acharya S. A review: Brief insight into Polycystic Ovarian syndrome. Endocrine and Metabolic Science 2021;3:100085. [DOI: 10.1016/j.endmts.2021.100085] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Dinsdale NL, Crespi BJ. Endometriosis and polycystic ovary syndrome are diametric disorders. Evol Appl 2021;14:1693-715. [PMID: 34295358 DOI: 10.1111/eva.13244] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
21 Kazemi M, Pierson RA, Parry SA, Kaviani M, Chilibeck PD. Obesity, but not hyperandrogenism or insulin resistance, predicts skeletal muscle mass in reproductive-aged women with polycystic ovary syndrome: A systematic review and meta-analysis of 45 observational studies. Obes Rev 2021;22:e13255. [PMID: 33855800 DOI: 10.1111/obr.13255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Moradi N, Bidgoli SA, Chaichian S. Ovarian cysts disappear after 14-day oral regimen of Korean red ginseng extract in letrozole-induced polycystic ovarian syndrome. Obstet Gynecol Sci 2021;64:274-83. [PMID: 33743577 DOI: 10.5468/ogs.20094] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Kunicki M, Smolarczyk R. Polycystic Ovary Syndrome and Fibrocystic Breast Disease: An Updated Review. Horm Metab Res 2021;53:219-24. [PMID: 33684949 DOI: 10.1055/a-1392-0938] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Wierman ME. Hyperandrogenic Anovulation: Differential Diagnosis and Evaluation. Endocrinol Metab Clin North Am 2021;50:1-10. [PMID: 33518178 DOI: 10.1016/j.ecl.2020.12.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Zhou J, Tan Y, Wang X, Zhu M. Paeoniflorin attenuates DHEA-induced polycystic ovary syndrome via inactivation of TGF-β1/Smads signaling pathway in vivo. Aging (Albany NY) 2021;13:7084-95. [PMID: 33638949 DOI: 10.18632/aging.202564] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
26 Liu C, Yue S, Solarz J, Lee J, Li L. Improving the sexual activity and reproduction of female zebrafish with high testosterone levels. Sci Rep 2021;11:3822. [PMID: 33589678 DOI: 10.1038/s41598-021-83085-4] [Reference Citation Analysis]
27 Mimouni NEH, Paiva I, Barbotin AL, Timzoura FE, Plassard D, Le Gras S, Ternier G, Pigny P, Catteau-Jonard S, Simon V, Prevot V, Boutillier AL, Giacobini P. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab 2021;33:513-530.e8. [PMID: 33539777 DOI: 10.1016/j.cmet.2021.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
28 Sucquart IE, Nagarkar R, Edwards MC, Rodriguez Paris V, Aflatounian A, Bertoldo MJ, Campbell RE, Gilchrist RB, Begg DP, Handelsman DJ, Padmanabhan V, Anderson RA, Walters KA. Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model. Endocrinology 2021;162:bqab020. [PMID: 33522579 DOI: 10.1210/endocr/bqab020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Cox MJ, Edwards MC, Rodriguez Paris V, Aflatounian A, Ledger WL, Gilchrist RB, Padmanabhan V, Handelsman DJ, Walters KA. Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model. Endocrinology 2020;161:bqaa061. [PMID: 32301482 DOI: 10.1210/endocr/bqaa061] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
30 Palomba S, Piltonen TT, Giudice LC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update 2021;27:584-618. [PMID: 33302299 DOI: 10.1093/humupd/dmaa051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
31 Morales-Ledesma L, Trujillo Hernández A, Ramírez MI, Rosas G, Linares R. Administration of a VIP-antagonist in vivo modifies ovarian hormone secretion in a rat model with polycystic ovary syndrome. Life Sci 2021;265:118792. [PMID: 33220286 DOI: 10.1016/j.lfs.2020.118792] [Reference Citation Analysis]
32 Steegers-Theunissen RPM, Wiegel RE, Jansen PW, Laven JSE, Sinclair KD. Polycystic Ovary Syndrome: A Brain Disorder Characterized by Eating Problems Originating during Puberty and Adolescence. Int J Mol Sci 2020;21:E8211. [PMID: 33153014 DOI: 10.3390/ijms21218211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
33 Dewailly D, Barbotin AL, Dumont A, Catteau-Jonard S, Robin G. Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome. Front Endocrinol (Lausanne) 2020;11:641. [PMID: 33013710 DOI: 10.3389/fendo.2020.00641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
34 Zhang C, Yu C, Lin Z, Pan H, Li K, Ma H. MiRNAs expression profiling of rat ovaries displaying PCOS with insulin resistance. Arch Gynecol Obstet 2020;302:1205-13. [PMID: 32757043 DOI: 10.1007/s00404-020-05730-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
35 Prieto-Sánchez MT, Hernández-Peñalver AI, Sánchez-Ferrer ML, Mendiola J, Torres-Cantero AM. Anogenital distance and anti-Müllerian hormone combined improves the diagnosis of polycystic ovary syndrome. Hum Fertil (Camb) 2020;:1-9. [PMID: 32713212 DOI: 10.1080/14647273.2020.1795574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Moghetti P, Tosi F. Insulin resistance and PCOS: chicken or egg? J Endocrinol Invest. 2021;44:233-244. [PMID: 32648001 DOI: 10.1007/s40618-020-01351-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
37 Gourbesville C, Kerlan V, Reznik Y. Le syndrome des ovaires polykystiques : quelles nouveautés en 2019 ?: Keeping up with PCOS in 2019. Ann Endocrinol (Paris) 2019;80 Suppl 1:S29-37. [PMID: 31606059 DOI: 10.1016/S0003-4266(19)30114-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Liang Y, Ming Q, Liang J, Zhang Y, Zhang H, Shen T. Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity - a preliminary report. Can J Physiol Pharmacol. 2020;98:803-809. [PMID: 32150694 DOI: 10.1139/cjpp-2019-0413] [Cited by in Crossref: 15] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
39 Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937. [PMID: 32244180 DOI: 10.1016/j.molmet.2020.01.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 72] [Article Influence: 18.5] [Reference Citation Analysis]
40 Ferreira SR, Goyeneche AA, Heber MF, Abruzzese GA, Telleria CM, Motta AB. Prenatally androgenized female rats develop uterine hyperplasia when adult. Molecular and Cellular Endocrinology 2020;499:110610. [DOI: 10.1016/j.mce.2019.110610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Ruddenklau A, Campbell RE. Neuroendocrine Impairments of Polycystic Ovary Syndrome. Endocrinology 2019;160:2230-42. [PMID: 31265059 DOI: 10.1210/en.2019-00428] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
42 Witchel SF, Teede HJ, Peña AS. Curtailing PCOS. Pediatr Res 2020;87:353-61. [PMID: 31627209 DOI: 10.1038/s41390-019-0615-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
43 Silva MSB, Giacobini P. Don't Trust Your Gut: When Gut Microbiota Disrupt Fertility. Cell Metab 2019;30:616-8. [PMID: 31577927 DOI: 10.1016/j.cmet.2019.09.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
44 Witchel SF, Burghard AC, Tao RH, Oberfield SE. The diagnosis and treatment of PCOS in adolescents: an update. Current Opinion in Pediatrics 2019;31:562-9. [DOI: 10.1097/mop.0000000000000778] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
45 Barbotin AL, Peigné M, Malone SA, Giacobini P. Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function. Neuroendocrinology 2019;109:218-29. [PMID: 31280262 DOI: 10.1159/000500689] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
46 Abbott DH, Dumesic DA, Levine JE. Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy. Expert Rev Endocrinol Metab 2019;14:131-43. [PMID: 30767580 DOI: 10.1080/17446651.2019.1576522] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 19.0] [Reference Citation Analysis]
47 Rodgers RJ, Suturina L, Lizneva D, Davies MJ, Hummitzsch K, Irving-Rodgers HF, Robertson SA. Is polycystic ovary syndrome a 20th Century phenomenon? Med Hypotheses 2019;124:31-4. [PMID: 30798911 DOI: 10.1016/j.mehy.2019.01.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
48 Ostadmohammadi V, Jamilian M, Bahmani F, Asemi Z. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome. J Ovarian Res 2019;12:5. [PMID: 30665436 DOI: 10.1186/s13048-019-0480-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]